Pharmaids Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.06",
    "chg": -1.33,
    "chgp": "-4.11%",
    "dir": -1,
    "prev_price": "32.39",
    "mcapval": "110.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "Sep 02, 03:30 PM",
    "curr_time": "22:25 PM",
    "last_traded_at": "Sep 02, 03:30 PM IST",
    "bse_nse_vol": "1.81 k",
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4179559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PharmaidsPharma_mojoScore_4179559.png",
        "date": "2026-09-02 10:10:26",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4163954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PharmaidsPharma_mojoScore_4163954.png",
        "date": "2026-08-21 10:10:24",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 21 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4151851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PharmaidsPharma_fintrenddot_4151851.png",
        "date": "2026-08-13 11:00:30",
        "description": "Pharmaids Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite some operational strengths, the company faces challenges in liquidity and profitability, reflected in its recent downgrade to a Strong Sell rating by MarketsMOJO."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4145072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PharmaidsPharma_mojoScore_4145072.png",
        "date": "2026-08-10 10:10:47",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Pharmaids Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-pharmaids-pharmaceuticals-ltd-4142385",
        "imagepath": "",
        "date": "2026-08-07 23:19:59",
        "description": "The next results date for Pharmaids Pharmaceuticals Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4128545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4128545.png",
        "date": "2026-07-30 10:10:29",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4107914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4107914.png",
        "date": "2026-07-19 10:10:27",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4093425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4093425.png",
        "date": "2026-07-08 10:10:56",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4074934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_mojoScore_4074934.png",
        "date": "2026-06-27 10:10:34",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 133,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Aug-2026",
      "details": "Enclosed copies of Newspaper Advertisement published on August 19 2026 intimating the Notice of 37th Annual General Meeting of the Company",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 37Th Annual General Meeting And Annual Report",
      "datetime": "18-Aug-2026",
      "details": "Notice of 37th AGM and Annual Report",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "18-Aug-2026",
      "details": "Annual Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-09-02 10:10:26

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-08-21 10:10:24

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 21 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-08-13 11:00:30

Pharmaids Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite some operational strengths, the company faces challenges in liquidity and profitability, reflected in its recent downgrade to a Strong Sell rating by MarketsMOJO.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-08-10 10:10:47

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Pharmaids Pharmaceuticals Ltd?

2026-08-07 23:19:59

The next results date for Pharmaids Pharmaceuticals Ltd is scheduled for 12 August 2026....

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-07-30 10:10:29

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-07-19 10:10:27

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-07-08 10:10:56

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-06-27 10:10:34

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News